Fundz

Lymphatica Medtech raised €17.9M in a Series B funding round to advance the development of LymphoDrain for treating lymphedema.

PRIVATEOct 08, 2024

Amount Raised

€17.9 Million

Round Type

Series B

LausanneBiotechnologyHealth CareMedicalMedical Device

Investors

High Tech GründerfondsClub Degli InvestitoriZürcher KantonalbankOccidentPanakès Partners

Description

Lymphatica Medtech, a clinical-stage company based in Lausanne, has successfully raised €17.9 million in Series B funding. This funding will be used to accelerate the development and validation of LymphoDrain, an innovative device aimed at treating lymphedema.

Quick answer

Lymphatica Medtech raised €17.9 Million in a Series B round, dated October 8, 2024. Investors: High Tech Gründerfonds, Club Degli Investitori, Zürcher Kantonalbank, Occident and Panakès Partners. Lymphatica Medtech is based in Lausanne, Vaud, Switzerland.

How much did Lymphatica Medtech raise?
Lymphatica Medtech raised €17.9 Million in a Series B round on October 8, 2024.
Who invested in Lymphatica Medtech?
High Tech Gründerfonds, Club Degli Investitori, Zürcher Kantonalbank, Occident and Panakès Partners are named as investors in this round.
What does Lymphatica Medtech do?
Lymphatica Medtech is a clinical-stage company based in Lausanne that focuses on developing innovative medical solutions for treating lymphedema.
Where is Lymphatica Medtech based and how big is it?
Lymphatica Medtech is based in Lausanne, Vaud, Switzerland.
Who are the decision-makers at Lymphatica Medtech?
Fundz holds 1 contact at Lymphatica Medtech. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Lymphatica Medtech, and when

A new round usually means Lymphatica Medtech is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lymphatica Medtech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lymphatica Medtech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lymphatica Medtech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lymphatica Medtech

Location

Lausanne, Vaud, Switzerland

About

Lymphatica Medtech is a clinical-stage company based in Lausanne that focuses on developing innovative medical solutions for treating lymphedema. Their flagship product, LymphoDrain, is an implantable device designed to restore lymphatic function. The company aims to improve the quality of life for individuals affected by this chronic condition. Currently, there is no cure for lymphedema.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lymphatica Medtech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Lymphatica Medtech's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Lymphatica Medtech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.